Díez-Villanueva, Anna
Jordà, Mireia
Carreras-Torres, Robert
Alonso, Henar
Cordero, David
Guinó, Elisabet
Sanjuan, Xavier
Santos, Cristina
Salazar, Ramón
Sanz-Pamplona, Rebeca
Moreno, Victor http://orcid.org/0000-0002-2818-5487
Funding for this research was provided by:
Instituto de Salud Carlos III (PI08-1635, PS09-1037, PI11-01439)
Departament d'Universitats, Recerca i Societat de la Informació (2017SGR723)
Fundación Científica Asociación Española Contra el Cáncer (GCTRA18022MORE)
FP7 Ideas: European Research Council (FP7-COOP-Health-2007-B HiPerDART)
National Institutes of Health (U19-CA148107, R01-CA201407)
Article History
Received: 13 April 2021
Accepted: 7 August 2021
First Online: 21 August 2021
Declarations
:
: The study was performed in accordance with relevant ethics guidelines and regulations. The Clinical Research Ethics Committee of the Bellvitge Hospital approved the study protocol (Number PR178/11), and all individuals provided written informed consent to participate and for genetic analyses to be done on their samples.
: Not applicable.
: VM is co-investigator in grants with Aniling S.L.